Safety and Efficacy of Brimonidine Tartrate Posterior Segment Drug Delivery System in Improving Visual Function
Status:
Completed
Trial end date:
2011-07-01
Target enrollment:
Participant gender:
Summary
This study will evaluate the efficacy and safety of the Brimo PS DDS® Applicator System (200
μg and 400 μg brimonidine tartrate) on visual function in patients with previous
rhegmatogenous macula-off retinal detachment.